Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCGR | P47871 | 2/20 | 0.43 |
| ▸ | CFTR | P13569 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.38 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5589592 | 0.82 | GCGR (0.46) | GCGRALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL5611497 | 0.81 | DCTPP1 (0.40) | GCGRALDH1A1KDM4EHSD11B1DCTPP1 | |
| SCHEMBL10985993 | 0.74 | GCGR (0.45) | GCGRALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL27876741 | 0.74 | GCGR (0.49) | GCGRALDH1A1KDM4EHSD17B10HSD11B1 | |
| SCHEMBL5589821 | 0.73 | DPP4 (0.45) | GCGRALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL11352114 | 0.72 | GCGR (0.46) | GCGRALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL2868213 | 0.72 | GCGR (0.40) | GCGRALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL28237950 | 0.72 | PDE4B (0.49) | GCGRALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL11241505 | 0.72 | GCGR (0.38) | GCGRALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL5587529 | 0.71 | KDM4E (0.39) | GCGRALDH1A1KDM4EHPGDLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7098225-B2 | Active compound combinations having insecticidal and acaricidal properties | BAYER AKTIENGESELLSCHAFT (DE) | 2006-08-29 | — | — | US | disclosed |
| US-20040209947-A1 | Active compound combinations having insecticidal and acaricidal properties | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2004-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040209947-A1 | Active compound combinations having insecticidal and acaricidal properties | AADAC, ACAA2, CYP51A1 | GCGR 2088/4885CFTR 3838/4885ALDH1A1 1437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.